Report Cover

Global Anti-Emetic Drug Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Oral
    Injection
    Others

Segment by Application
    Hospital
    Clinic
    Home Care
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Merck
    Novartis
    Glenmark Pharmaceuticals
    F. Hoffmann-La Roche
    Heron Therapeutics
    Kyowa Kirin
    Aurobindo Pharma
    Mylan
    Hikma
    Akorn
    Dr. Reddy's Laboratories
    Cipla
    Fresenius Kabi
    Wockhardt
    Sun Pharmaceutical Industries
    Teva Pharmaceutical
    Pfizer
1 Anti-Emetic Drug Market Overview
    1.1 Product Overview and Scope of Anti-Emetic Drug
    1.2 Anti-Emetic Drug Segment by Type
        1.2.1 Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Oral
        1.2.3 Injection
        1.2.4 Others
    1.3 Anti-Emetic Drug Segment by Application
        1.3.1 Anti-Emetic Drug Sales Comparison by Application: (2021-2027)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Care
        1.3.5 Others
    1.4 Global Anti-Emetic Drug Market Size Estimates and Forecasts
        1.4.1 Global Anti-Emetic Drug Revenue 2016-2027
        1.4.2 Global Anti-Emetic Drug Sales 2016-2027
        1.4.3 Anti-Emetic Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-Emetic Drug Market Competition by Manufacturers
    2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Anti-Emetic Drug Manufacturing Sites, Area Served, Product Type
    2.5 Anti-Emetic Drug Market Competitive Situation and Trends
        2.5.1 Anti-Emetic Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Anti-Emetic Drug Players Market Share by Revenue
        2.5.3 Global Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-Emetic Drug Retrospective Market Scenario by Region
    3.1 Global Anti-Emetic Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Anti-Emetic Drug Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Anti-Emetic Drug Market Facts & Figures by Country
        3.3.1 North America Anti-Emetic Drug Sales by Country
        3.3.2 North America Anti-Emetic Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Anti-Emetic Drug Market Facts & Figures by Country
        3.4.1 Europe Anti-Emetic Drug Sales by Country
        3.4.2 Europe Anti-Emetic Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Anti-Emetic Drug Sales by Region
        3.5.2 Asia Pacific Anti-Emetic Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Anti-Emetic Drug Market Facts & Figures by Country
        3.6.1 Latin America Anti-Emetic Drug Sales by Country
        3.6.2 Latin America Anti-Emetic Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Anti-Emetic Drug Sales by Country
        3.7.2 Middle East and Africa Anti-Emetic Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Anti-Emetic Drug Historic Market Analysis by Type
    4.1 Global Anti-Emetic Drug Sales Market Share by Type (2016-2021)
    4.2 Global Anti-Emetic Drug Revenue Market Share by Type (2016-2021)
    4.3 Global Anti-Emetic Drug Price by Type (2016-2021)

5 Global Anti-Emetic Drug Historic Market Analysis by Application
    5.1 Global Anti-Emetic Drug Sales Market Share by Application (2016-2021)
    5.2 Global Anti-Emetic Drug Revenue Market Share by Application (2016-2021)
    5.3 Global Anti-Emetic Drug Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Merck Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Novartis
        6.2.1 Novartis Corporation Information
        6.2.2 Novartis Description and Business Overview
        6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Novartis Product Portfolio
        6.2.5 Novartis Recent Developments/Updates
    6.3 Glenmark Pharmaceuticals
        6.3.1 Glenmark Pharmaceuticals Corporation Information
        6.3.2 Glenmark Pharmaceuticals Description and Business Overview
        6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Glenmark Pharmaceuticals Product Portfolio
        6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
    6.4 F. Hoffmann-La Roche
        6.4.1 F. Hoffmann-La Roche Corporation Information
        6.4.2 F. Hoffmann-La Roche Description and Business Overview
        6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 F. Hoffmann-La Roche Product Portfolio
        6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
    6.5 Heron Therapeutics
        6.5.1 Heron Therapeutics Corporation Information
        6.5.2 Heron Therapeutics Description and Business Overview
        6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Heron Therapeutics Product Portfolio
        6.5.5 Heron Therapeutics Recent Developments/Updates
    6.6 Kyowa Kirin
        6.6.1 Kyowa Kirin Corporation Information
        6.6.2 Kyowa Kirin Description and Business Overview
        6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Kyowa Kirin Product Portfolio
        6.6.5 Kyowa Kirin Recent Developments/Updates
    6.7 Aurobindo Pharma
        6.6.1 Aurobindo Pharma Corporation Information
        6.6.2 Aurobindo Pharma Description and Business Overview
        6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Aurobindo Pharma Product Portfolio
        6.7.5 Aurobindo Pharma Recent Developments/Updates
    6.8 Mylan
        6.8.1 Mylan Corporation Information
        6.8.2 Mylan Description and Business Overview
        6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Mylan Product Portfolio
        6.8.5 Mylan Recent Developments/Updates
    6.9 Hikma
        6.9.1 Hikma Corporation Information
        6.9.2 Hikma Description and Business Overview
        6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Hikma Product Portfolio
        6.9.5 Hikma Recent Developments/Updates
    6.10 Akorn
        6.10.1 Akorn Corporation Information
        6.10.2 Akorn Description and Business Overview
        6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Akorn Product Portfolio
        6.10.5 Akorn Recent Developments/Updates
    6.11 Dr. Reddy's Laboratories
        6.11.1 Dr. Reddy's Laboratories Corporation Information
        6.11.2 Dr. Reddy's Laboratories Anti-Emetic Drug Description and Business Overview
        6.11.3 Dr. Reddy's Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Dr. Reddy's Laboratories Product Portfolio
        6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
    6.12 Cipla
        6.12.1 Cipla Corporation Information
        6.12.2 Cipla Anti-Emetic Drug Description and Business Overview
        6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Cipla Product Portfolio
        6.12.5 Cipla Recent Developments/Updates
    6.13 Fresenius Kabi
        6.13.1 Fresenius Kabi Corporation Information
        6.13.2 Fresenius Kabi Anti-Emetic Drug Description and Business Overview
        6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Fresenius Kabi Product Portfolio
        6.13.5 Fresenius Kabi Recent Developments/Updates
    6.14 Wockhardt
        6.14.1 Wockhardt Corporation Information
        6.14.2 Wockhardt Anti-Emetic Drug Description and Business Overview
        6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Wockhardt Product Portfolio
        6.14.5 Wockhardt Recent Developments/Updates
    6.15 Sun Pharmaceutical Industries
        6.15.1 Sun Pharmaceutical Industries Corporation Information
        6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description and Business Overview
        6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Sun Pharmaceutical Industries Product Portfolio
        6.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
    6.16 Teva Pharmaceutical
        6.16.1 Teva Pharmaceutical Corporation Information
        6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description and Business Overview
        6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Teva Pharmaceutical Product Portfolio
        6.16.5 Teva Pharmaceutical Recent Developments/Updates
    6.17 Pfizer
        6.17.1 Pfizer Corporation Information
        6.17.2 Pfizer Anti-Emetic Drug Description and Business Overview
        6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Pfizer Product Portfolio
        6.17.5 Pfizer Recent Developments/Updates

7 Anti-Emetic Drug Manufacturing Cost Analysis
    7.1 Anti-Emetic Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Anti-Emetic Drug
    7.4 Anti-Emetic Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Anti-Emetic Drug Distributors List
    8.3 Anti-Emetic Drug Customers

9 Anti-Emetic Drug Market Dynamics
    9.1 Anti-Emetic Drug Industry Trends
    9.2 Anti-Emetic Drug Growth Drivers
    9.3 Anti-Emetic Drug Market Challenges
    9.4 Anti-Emetic Drug Market Restraints

10 Global Market Forecast
    10.1 Anti-Emetic Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Anti-Emetic Drug by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Anti-Emetic Drug by Type (2022-2027)
    10.2 Anti-Emetic Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Anti-Emetic Drug by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Anti-Emetic Drug by Application (2022-2027)
    10.3 Anti-Emetic Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Anti-Emetic Drug by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Anti-Emetic Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Anti-Emetic Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Anti-Emetic Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Anti-Emetic Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Anti-Emetic Drug Covered in This Study Table 5. Global Anti-Emetic Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Anti-Emetic Drug Sales Share by Manufacturers (2016-2021) Table 7. Global Anti-Emetic Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Anti-Emetic Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Anti-Emetic Drug Manufacturing Sites and Area Served Table 11. Manufacturers Anti-Emetic Drug Product Type Table 12. Global Anti-Emetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Emetic Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Anti-Emetic Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Anti-Emetic Drug Sales Market Share by Region (2016-2021) Table 17. Global Anti-Emetic Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Anti-Emetic Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Anti-Emetic Drug Sales Market Share by Country (2016-2021) Table 20. North America Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Anti-Emetic Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Anti-Emetic Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Anti-Emetic Drug Sales Market Share by Country (2016-2021) Table 24. Europe Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Anti-Emetic Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Anti-Emetic Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Anti-Emetic Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Anti-Emetic Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Anti-Emetic Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Anti-Emetic Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Anti-Emetic Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country (2016-2021) Table 38. Global Anti-Emetic Drug Sales (K Units) by Type (2016-2021) Table 39. Global Anti-Emetic Drug Sales Market Share by Type (2016-2021) Table 40. Global Anti-Emetic Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Anti-Emetic Drug Revenue Share by Type (2016-2021) Table 42. Global Anti-Emetic Drug Price (US$/Unit) by Type (2016-2021) Table 43. Global Anti-Emetic Drug Sales (K Units) by Application (2016-2021) Table 44. Global Anti-Emetic Drug Sales Market Share by Application (2016-2021) Table 45. Global Anti-Emetic Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Anti-Emetic Drug Revenue Share by Application (2016-2021) Table 47. Global Anti-Emetic Drug Price (US$/Unit) by Application (2016-2021) Table 48. Merck Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Merck Anti-Emetic Drug Product Table 52. Merck Recent Developments/Updates Table 53. Novartis Corporation Information Table 54. Novartis Description and Business Overview Table 55. Novartis Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Novartis Anti-Emetic Drug Product Table 57. Novartis Recent Developments/Updates Table 58. Glenmark Pharmaceuticals Corporation Information Table 59. Glenmark Pharmaceuticals Description and Business Overview Table 60. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Glenmark Pharmaceuticals Anti-Emetic Drug Product Table 62. Glenmark Pharmaceuticals Recent Developments/Updates Table 63. F. Hoffmann-La Roche Corporation Information Table 64. F. Hoffmann-La Roche Description and Business Overview Table 65. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. F. Hoffmann-La Roche Anti-Emetic Drug Product Table 67. F. Hoffmann-La Roche Recent Developments/Updates Table 68. Heron Therapeutics Corporation Information Table 69. Heron Therapeutics Description and Business Overview Table 70. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Heron Therapeutics Anti-Emetic Drug Product Table 72. Heron Therapeutics Recent Developments/Updates Table 73. Kyowa Kirin Corporation Information Table 74. Kyowa Kirin Description and Business Overview Table 75. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Kyowa Kirin Anti-Emetic Drug Product Table 77. Kyowa Kirin Recent Developments/Updates Table 78. Aurobindo Pharma Corporation Information Table 79. Aurobindo Pharma Description and Business Overview Table 80. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Aurobindo Pharma Anti-Emetic Drug Product Table 82. Aurobindo Pharma Recent Developments/Updates Table 83. Mylan Corporation Information Table 84. Mylan Description and Business Overview Table 85. Mylan Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Mylan Anti-Emetic Drug Product Table 87. Mylan Recent Developments/Updates Table 88. Hikma Corporation Information Table 89. Hikma Description and Business Overview Table 90. Hikma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Hikma Anti-Emetic Drug Product Table 92. Hikma Recent Developments/Updates Table 93. Akorn Corporation Information Table 94. Akorn Description and Business Overview Table 95. Akorn Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Akorn Anti-Emetic Drug Product Table 97. Akorn Recent Developments/Updates Table 98. Dr. Reddy's Laboratories Corporation Information Table 99. Dr. Reddy's Laboratories Description and Business Overview Table 100. Dr. Reddy's Laboratories Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Dr. Reddy's Laboratories Anti-Emetic Drug Product Table 102. Dr. Reddy's Laboratories Recent Developments/Updates Table 103. Cipla Corporation Information Table 104. Cipla Description and Business Overview Table 105. Cipla Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Cipla Anti-Emetic Drug Product Table 107. Cipla Recent Developments/Updates Table 108. Fresenius Kabi Corporation Information Table 109. Fresenius Kabi Description and Business Overview Table 110. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Fresenius Kabi Anti-Emetic Drug Product Table 112. Fresenius Kabi Recent Developments/Updates Table 113. Wockhardt Corporation Information Table 114. Wockhardt Description and Business Overview Table 115. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Wockhardt Anti-Emetic Drug Product Table 117. Wockhardt Recent Developments/Updates Table 118. Sun Pharmaceutical Industries Corporation Information Table 119. Sun Pharmaceutical Industries Description and Business Overview Table 120. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Sun Pharmaceutical Industries Anti-Emetic Drug Product Table 122. Sun Pharmaceutical Industries Recent Developments/Updates Table 123. Teva Pharmaceutical Corporation Information Table 124. Teva Pharmaceutical Description and Business Overview Table 125. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Teva Pharmaceutical Anti-Emetic Drug Product Table 127. Teva Pharmaceutical Recent Developments/Updates Table 128. Pfizer Corporation Information Table 129. Pfizer Description and Business Overview Table 130. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Pfizer Anti-Emetic Drug Product Table 132. Pfizer Recent Developments/Updates Table 133. Production Base and Market Concentration Rate of Raw Material Table 134. Key Suppliers of Raw Materials Table 135. Anti-Emetic Drug Distributors List Table 136. Anti-Emetic Drug Customers List Table 137. Anti-Emetic Drug Market Trends Table 138. Anti-Emetic Drug Growth Drivers Table 139. Anti-Emetic Drug Market Restraints Table 140. Global Anti-Emetic Drug Sales Forecast by Type (2022-2027) & (K Units) Table 141. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2022-2027) Table 142. Global Anti-Emetic Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 143. Global Anti-Emetic Drug Revenue Market Share Forecast by Type (2022-2027) Table 144. Global Anti-Emetic Drug Sales Forecast by Application (2022-2027) & (K Units) Table 145. Global Anti-Emetic Drug Sales Market Share Forecast by Application (2022-2027) Table 146. Global Anti-Emetic Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 147. Global Anti-Emetic Drug Revenue Market Share Forecast by Application (2022-2027) Table 148. Global Anti-Emetic Drug Sales Forecast by Region (2022-2027) & (K Units) Table 149. Global Anti-Emetic Drug Sales Market Share Forecast by Region (2022-2027) Table 150. Global Anti-Emetic Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 151. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2022-2027) Table 152. Research Programs/Design for This Report Table 153. Key Data Information from Secondary Sources Table 154. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Anti-Emetic Drug Figure 2. Global Anti-Emetic Drug Market Share by Type in 2020 & 2027 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. Others Product Picture Figure 6. Global Anti-Emetic Drug Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinic Figure 9. Home Care Figure 10. Others Figure 11. Global Anti-Emetic Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Anti-Emetic Drug Market Size 2016-2027 (US$ Million) Figure 13. Global Anti-Emetic Drug Sales 2016-2027 (K Units) Figure 14. Global Anti-Emetic Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Anti-Emetic Drug Sales Share by Manufacturers in 2020 Figure 16. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Anti-Emetic Drug Players: Market Share by Revenue in 2020 Figure 18. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Anti-Emetic Drug Sales Market Share by Region (2016-2021) Figure 20. Global Anti-Emetic Drug Sales Market Share by Region in 2020 Figure 21. Global Anti-Emetic Drug Revenue Market Share by Region (2016-2021) Figure 22. Global Anti-Emetic Drug Revenue Market Share by Region in 2020 Figure 23. U.S. Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. UAE Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Anti-Emetic Drug by Type (2016-2021) Figure 48. Sales Market Share of Anti-Emetic Drug by Application (2016-2021) Figure 49. Sales Market Share of Anti-Emetic Drug by Application in 2020 Figure 50. Revenue Share of Anti-Emetic Drug by Application (2016-2021) Figure 51. Revenue Share of Anti-Emetic Drug by Application in 2020 Figure 52. Manufacturing Cost Structure of Anti-Emetic Drug Figure 53. Manufacturing Process Analysis of Anti-Emetic Drug Figure 54. Anti-Emetic Drug Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us